Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03745716
Brief Title: APR-246 & Azacitidine for the Treatment of TP53 Mutant Myelodysplastic Syndromes (MDS)

First Submitted : November 14, 2018
First Submitted that Met QC Criteria : November 16, 2018
First Posted : November 19, 2018

Last Update Submitted that Met QC Criteria : July 28, 2021
Last Update Posted : July 29, 2021